EFV
Eva Fortea Verdejo Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
19
Avg Return
Past Year
Past Year
33%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
62.1%
Neutral
34.5%
Negative
3.4%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Upgraded
| $13 |
63%
upside
| 2 | +2.6% |
0
%
| 12 Dec ‘25 1 month ago |
|
|
|
Overweight
Upgraded
| $33 |
42%
upside
| 4 | -7.1% |
0
%
| 12 Dec ‘25 1 month ago |
|
|
|
Equal-Weight
Maintained
| $11 |
39%
downside
| 3 | -33% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Overweight
Initiated
| $60 |
82%
upside
| 1 | +2.5% |
0
%
| 31 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $29 |
38%
upside
| 3 | +39% |
0
%
| 20 Oct ‘25 2 months ago |
|
|
|
Equal-Weight
Downgraded
| $97 | – | 5 | +46% |
0
%
| 30 Sep ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $45 |
5%
upside
| 2 | +25% |
0
%
| 25 Sep ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $70 |
41%
downside
| 1 | +193% |
0
%
| 11 Sep ‘25 4 months ago |
|
|
|
Equal-Weight
Maintained
| $11 | – | 5 | +5.7% |
0
%
| 7 Aug ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $27 |
94%
upside
| 2 | +18% |
0
%
| 7 Aug ‘25 5 months ago |
|
|
|
Overweight
Initiated
| $44 |
18%
upside
| 1 | +70% |
0
%
| 26 Jun ‘25 6 months ago |
|